Drug Type ASO |
Synonyms Antisense oligonucleotide HBx protein, HBx gene antagonist, SB11527 + [1] |
Target |
Action inhibitors |
Mechanism HBsAg inhibitors(HBsAg inhibitors), Hepatitis B virus replication inhibitors, RNAi(RNA interference) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B | Preclinical | United States | 20 Nov 2020 |





